Conway Stuart Stretta GERD Clearance Expected By April 2000
This article was originally published in The Gray Sheet
Executive Summary
Conway Stuart's Stretta radiofrequency ablation catheter and control module could gain 510(k) approval for the treatment of gastroesophageal reflux disease (GERD) as early as April 2000, company founder Stuart Edwards reported Oct. 28.
You may also be interested in...
Advanced UroScience Durasphere Post-Approval Study Focuses On Durability
Advanced UroScience's post-approval study of its Durasphere bulking agent for treatment of female stress urinary incontinence due to intrinsic sphincter deficiency will focus on evaluating the durability of the product, the company reports.
Bard Anticipating Endoscopic Suturing Device Sales By Second Quarter 2000
Bard expects to add roughly $5 mil. to its top line during the first year of sales of its endoscopic suturing device for treatment of severe gastroesophageal reflux disease (GERD).
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.